Navigation Links
Pharmaceutical companies are targeting patients

TV viewers are right if they are feeling bombarded by commercials. Drug company advertising aimed at ordinary people instead of doctors tripled in the U.S. between 1996 and 2000 to nearly $2.5 billion a year. Advertisements targeting consumers account for 15% of U.S. spending to promote medications, up from almost 9% in 1996.//

Spending that targets doctors - including visits from sales representatives, free samples and medical journal ads - decreased from 91% to 84% during the same period. They analyzed data on media advertising and sales of individual drugs, examining trends since 1996, the year before the Food and Drug Administration issued rules for television ads on prescription drugs.

Critics argue that drug ads aimed at ordinary people encourage use of expensive, sometimes unnecessary medicines, appeal to patients' emotions, undermine the doctor-patient relationship and rarely tell patients about the drugs' success rate, alternative treatments and other key information.

The pharmaceutical industry argues the ads inform and educate consumers, prompt many to see their doctor about an untreated health problem and prod others to take their prescription drugs more faithfully. Sixty percent of the print and broadcast ads were for just 20 medications, including the arthritis drugs Vioxx and Celebrex, the ulcer drug Prilosec, Viagra for impotence and the allergy drugs Claritin, Allegra and Zyrtec.
'"/>




Page: 1

Related medicine news :

1. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
2. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
3. Medicis Pharmaceutical company enters pediatric market
4. FDA approves Watson Pharmaceuticals Oxytrol patch
5. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
6. Indian Pharmaceutical Industries Stops Manufacturing And Sale Of Valdecoxib
7. Pharmaceutical industries grant for R&D to be monitored
8. Japanese And Chinese Pharmaceutical Companies Join Together In Drug Testing
9. Antigenics Pharmaceuticals plans for Phase III trial of its Melanoma vaccine
10. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
11. Top Pharmaceuticals Influence Doctors Prescriptions
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/5/2016)... ... February 05, 2016 , ... VeloReality President ... next generation LYNX VR Indoor Trainer with multi-rider capability to an enthusiastic audience ... not only reduce the weight of the unit, they also enhance the rider's ...
(Date:2/5/2016)... ... February 05, 2016 , ... Francisco Canales, MD and Heather ... Napa Valley office. The technique utilizes the body’s own healing abilities to quickly ... Furnas, are part of only a select few cosmetic surgeons bringing this procedure ...
(Date:2/5/2016)... ... February 05, 2016 , ... US Sports Camps , official ... NH to direct high-performance kids yoga training. ChildLight Yoga Studio is centrally situated in ... from Boston. , ChildLight Yoga Studio founder Lisa Flynn expresses her excitement, “We are ...
(Date:2/5/2016)... ... ... Boar’s Head Brand®, one of the nation’s leading providers of premium delicatessen foods, ... out of your party preparation – follow these easy, yet delicious recipes with the ... , “The key to hosting a successful game-day party is creating a flavorful menu ...
(Date:2/5/2016)... Francisco, CA (PRWEB) , ... February 05, 2016 ... ... and founder of CitiDent, announces that it is now welcoming orthodontist, ... Dr. Cheng, CitiDent offers a complete range of oral health care, including general ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... -- Mettler-Toledo International Inc. (NYSE: MTD ) today ... the highlights: , Sales in local currency ... year.  Reported sales decreased 3% as currency reduced sales ... earnings per diluted share as reported (EPS) were $4.44, ... EPS was $4.65, an increase of 10% over the ...
(Date:2/4/2016)... -- In response to the opioid abuse epidemic, today Dr. ... Products and Tobacco, along with other FDA leaders, called for ... opioid medications. The plan will focus on policies aimed at ... to effective relief. --> ... risk-benefit paradigm for opioids and ensure that the agency considers ...
(Date:2/4/2016)... 2016  Blueprint Medicines Corporation (NASDAQ: BPMC ... selective investigational kinase medicines for patients with genomically ... board of directors of Lonnel Coats , ... of industry-related experience. Jeffrey Albers ... strong strategic experience developing and commercializing numerous oncology ...
Breaking Medicine Technology: